Table 1.
Demographic and clinical landscape of the 172 CRC patients in this study
| Characteristics | Number of patients (%) | |
|---|---|---|
| Sex | Male | 112 (65.1%) |
| Female | 60 (34.9%) | |
| Tumor sidedness | Left | 125 (72.7%) |
| Right | 47 (27.3%) | |
| Age | >=50 | 157 (91.3%) |
| <50, >=45 | 11 (6.4%) | |
| >45 | 4 (2.3%) | |
| CA19-9 | >=25 | 35 (20.3%) |
| <25 | 137 (79.7%) | |
| CEA | >=5 | 53 (30.8%) |
| <5 | 119 (69.2%) | |
| TNM T Stage | T1 | 19 (11.0%) |
| T2 | 27 (15.7%) | |
| T3 | 94 (54.7%) | |
| T4 | 32 (18.6%) | |
| TNM N Stage | N0 | 93 (54.1%) |
| N1 | 79 (45.9%) | |
| TNM M stage | M0 | 144 (83.7%) |
| M1 | 28 (16.3%) | |
| MSI | MSS | 165 (95.9%) |
| MSI | 7 (4.1%) | |
| Lymphovascular invasion (LVI) | Without LVI | 81 (47.1%) |
| With LVI | 91 (52.9%) | |
| Diabetes mellitus | Without diabetes mellitus | 134 (77.9%) |
| With diabetes mellitus | 38 (22.1%) | |
| BMI | >=25 | 45 (26.2%) |
| <25 | 127 (73.8%) | |
| ECOG performance status | 0 | 51 (29.7%) |
| 1 | 97 (56.4%) | |
| 2 | 24 (13.9%) | |
| Synchronous lung metastasis | No | 169 (98.3%) |
| Yes | 3 (1.7%) | |
| Synchronous liver metastasis | No | 155 (90.1%) |
| Yes | 17 (9.9%) | |
| Bowel obstruction | No | 128 (74.4%) |
| Yes | 44 (25.6%) | |